
Mallinckrodt To Fund $10M In Research At Washington University School of Medicine [Education News]
Pharmaceutical manufacturer Mallinckrodt has announced plans to spend up to $10 million over five years to fund research at the Washington University School of Medicine in St. Louis. The St. Louis Post-Dispatch reports that the partnership will fund projects that have a focus on rare diseases. Mallinckrodt's Chief Scientific Officer, Dr. Steven Romano, says many underserved patients have "few, if any, therapeutic options."